CEREBROSPINAL FLUID PENETRATION OF PEXIDARTINIB (PLX3397), A CSF1R INHIBITOR, IN A NONHUMAN PRIMATE MODEL

被引：0
|
作者：
Odabas, Arman [1 ]
McCully, Cynthia M. Lester [1 ]
Cruz, Rafael [1 ]
Figg, William D. [1 ]
Glod, John [1 ]
Rymar, Andrey [2 ]
Peer, Cody [1 ]
Warren, Katherine E. [1 ]
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PHRM-03
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Dynamic changes in microglia in the mouse hippocampus during administration and withdrawal of the CSF1R inhibitor PLX3397
    Wang, Qirun
    Wang, Yi-Yan
    Pu, Wen-Jun
    Ma, Xiaohong
    Ni, Rong-Jun
    JOURNAL OF ANATOMY, 2023, 243 (03) : 394 - 403
  • [2] PHASE IB STUDY OF PLX3397, A CSF1R INHIBITOR, AND PACLITAXEL IN PATIENTS WITH ADVANCED SOLID TUMORS
    Rugo, H. S.
    Sharma, N.
    Reebel, L.
    Rodal, M. B.
    Peck, A.
    West, B. L.
    Marimuthu, A.
    Karlin, D. A.
    Dowlati, A.
    Le, M. H.
    Coussens, L. M.
    Wesolowski, R.
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model
    Tahmasebi, Fatemeh
    Pasbakhsh, Parichehr
    Mortezaee, Keywan
    Madadi, Soheila
    Barati, Shirin
    Kashani, Iraj Ragerdi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) : 10576 - 10586
  • [4] CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
    Fujiwara, Tomohiro
    Yakoub, Mohamed A.
    Chandler, Andrew
    Christ, Alexander B.
    Yang, Guangli
    Ouerfelli, Ouathek
    Rajasekhar, Vinagolu K.
    Yoshida, Aki
    Kondo, Hiroya
    Hata, Toshiaki
    Tazawa, Hiroshi
    Dogan, Yildirim
    Moore, Malcolm A. S.
    Fujiwara, Toshiyoshi
    Ozaki, Toshifumi
    Purdue, Ed
    Healey, John H.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (08) : 1388 - 1399
  • [5] Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors
    Wesolowski, Robert
    Sharma, Neelesh
    Reebel, Laura
    Rodal, Mary Beth
    Peck, Alexandra
    West, Brian L.
    Marimuthu, Adhirai
    Severson, Paul
    Karlin, David A.
    Dowlati, Afshin
    Le, Mai H.
    Coussens, Lisa M.
    Rugo, Hope S.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [6] CSF1R inhibitor PLX3397 depletes microglia in Mongolian gerbil Meriones unguiculatus, but not in syrian hamster Mesocricetus auratus
    Sato, Ren Y.
    Zhang, Yumin
    Kotake, Koki T.
    Onishi, Hiraku
    Ito, Shiho
    Norimoto, Hiroaki
    Zhou, Zhiwen
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2024, 155 (02) : 29 - 34
  • [7] Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells
    Akhabue K. Okojie
    Joseph O. Uweru
    Morgan A. Coburn
    Sihan Li
    Vivian D. Cao-Dao
    Ukpong B. Eyo
    Journal of Neuroinflammation, 20
  • [8] Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells
    Okojie, Akhabue K.
    Uweru, Joseph O.
    Coburn, Morgan A.
    Li, Sihan
    Cao-Dao, Vivian D.
    Eyo, Ukpong B.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [9] The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice
    Merry, Troy L.
    Brooks, Anna E. S.
    Masson, Stewart W.
    Adams, Shannon E.
    Jaiswal, Jagdish K.
    Jamieson, Stephen M. F.
    Shepherd, Peter R.
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (01) : 245 - 253
  • [10] The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice
    Troy L. Merry
    Anna E. S. Brooks
    Stewart W. Masson
    Shannon E. Adams
    Jagdish K. Jaiswal
    Stephen M. F. Jamieson
    Peter R. Shepherd
    International Journal of Obesity, 2020, 44 : 245 - 253
12345